TECLISON Trademark

Trademark Overview

On Monday, May 2, 2022, a trademark application was filed for TECLISON with the United States Patent and Trademark Office. The USPTO has given the TECLISON trademark a serial number of 97391499. The federal status of this trademark filing is REGISTERED as of Tuesday, August 27, 2024. This trademark is owned by TECLISON, INC.. The TECLISON trademark is filed in the Pharmaceutical Products category with the following description:

Prescribed pharmaceutical preparations for the treatment of cancer
teclison

General Information

Serial Number97391499
Word MarkTECLISON
Filing DateMonday, May 2, 2022
Status700 - REGISTERED
Status DateTuesday, August 27, 2024
Registration Number7489574
Registration DateTuesday, August 27, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Goods and ServicesPrescribed pharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code005
First Use Anywhere DateWednesday, March 6, 2024
First Use In Commerce DateWednesday, March 6, 2024

Trademark Owner History

Party NameTECLISON, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameTECLISON, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameTECLISON, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Thursday, May 5, 2022NEW APPLICATION ENTERED
Friday, May 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 21, 2023ASSIGNED TO EXAMINER
Tuesday, February 28, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 28, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 9, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2024USE AMENDMENT FILED
Wednesday, August 9, 2023SOU EXTENSION 1 FILED
Wednesday, August 9, 2023SOU EXTENSION 1 GRANTED
Thursday, April 18, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, May 14, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 14, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 14, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 25, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 25, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 27, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

teclison cancer treatment preparations pharmaceutical prescribed